Actinium Pharmaceuticals
ATNM
#10564
Rank
NZ$61.75 M
Marketcap
NZ$1.96
Share price
1.85%
Change (1 day)
-30.13%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): NZ$17.41 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$35.09 Million. In 2025 the company made an earning of -NZ$64.73 Million, an increase over its 2024 earnings that were of -NZ$75.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$17.41 M-126.91%
2025 -NZ$64.73 Million-13.95%
2024 -NZ$75.22 Million-18.87%
2023 -NZ$92.72 Million52.24%
2022 -NZ$60.9 Million36.61%
2021 -NZ$44.58 Million11.48%
2020 -NZ$39.99 Million1.46%
2019 -NZ$39.42 Million-7.37%
2018 -NZ$42.55 Million-11.46%
2017 -NZ$48.06 Million10.67%
2016 -NZ$43.43 Million15.7%
2015 -NZ$37.54 Million-14.86%
2014 -NZ$44.09 Million129.19%
2013 -NZ$19.24 Million-8.55%
2012 -NZ$21.04 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$66.42 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.34 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA